Evidence map›Paper›PMID 20164173›Full record

ArticleThe Journal of biological chemistry2010

Structural and functional characterization of SporoSAG: a SAG2-related surface antigen from Toxoplasma gondii.

Joanna Crawford, Erika Lamb, James Wasmuth, Ognjen Grujic, Michael E Grigg, Martin J Boulanger

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Bioactive materials · 2025
    Article
  2. Molecular characterization ofRoyal Society open science · 2025
    Article
  3. Proteomic identification of aFEMS microbes · 2025
    Article
  4. Limited value of current and newFrontiers in parasitology · 2023
    Article
  5. Frontiers in cellular and infection microbiology · 2022
    Review
  6. New Avenues to DesignFrontiers in immunology · 2022
    Article
  7. Identification of Oocyst-DrivenMicroorganisms · 2021
    Review
  8. Review
  9. Descriptive Comparison of ELISAs for the Detection ofPathogens (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Joanna CrawfordDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8W 3P6, Canada.
Erika Lamb
James Wasmuth
Ognjen Grujic
Michael E Grigg
Martin J Boulanger
University of Victoria · CAHospital for Sick Children · CANational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Toxoplasma Surface Antigens and ImmunityZIAAI001017 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GRIGG, MICHAEL · 2009 to 2025
$9.9M
Canadian Institutes of Health Research MOP8291Canadian Institutes of Health Research MOP84556Intramural NIH HHS
6 · The paper itself

Abstract

Toxoplasma gondii, the etiological agent of toxoplasmosis, utilizes stage-specific expression of antigenically distinct glycosylphosphatidylinositol-tethered surface coat proteins to promote and establish chronic infection. Of the three infective stages of T. gondii, sporozoites are encapsulated in highly infectious oocysts that have been linked to large scale outbreaks of toxoplasmosis. SporoSAG (surface antigen glycoprotein) is the dominant surface coat protein expressed on the surface of sporozoites. Using a bioinformatic approach, we show that SporoSAG clusters with the SAG2 subfamily of the SAG1-related superfamily (SRS) and is non-polymorphic among the 11 haplogroups of T. gondii strains. In contrast to the immunodominant SAG1 protein expressed on tachyzoites, SporoSAG is non-immunogenic during natural infection. We report the 1.60 A resolution crystal structure of SporoSAG solved using cadmium single anomalous dispersion. SporoSAG crystallized as a monomer and displays unique features of the SRS beta-sandwich fold relative to SAG1 and BSR4. Intriguingly, the structural diversity is localized to the upper sheets of the beta-sandwich fold and may have important implications for multimerization and host cell ligand recognition. The structure of SporoSAG also reveals an unexpectedly acidic surface that contrasts with the previously determined SAG1 and BSR4 structures where a basic surface is predicted to play a role in binding negatively charged glycosaminoglycans. Our structural and functional characterization of SporoSAG provides a rationale for the evolutionary divergence of this key SRS family member.

Indexed as

AnimalsAntibodies, ProtozoanAntigens, ProtozoanAntigens, SurfaceBase SequenceCrystallography, X-RayDNA, ProtozoanGenes, ProtozoanHumansModels, MolecularPhylogenyProtein Structure, SecondaryProtozoan ProteinsRecombinant ProteinsStatic ElectricityToxoplasmaAntibodies, ProtozoanAntigens, ProtozoanAntigens, SurfaceDNA, ProtozoanProtozoan ProteinsRecombinant ProteinsSAG1 antigen, Toxoplasmasurface antigen P22, Toxoplasma

Identifiers

PMID20164173
PMCPMC2852944
OpenAlexW1974981371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.